Keyword Connections

antisense

Journals

2

1 nanomedicine (london, england)

2 Environmental science & technology

Research Groups

0

No Research Group Connected

Bibliographies

31

1 AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

2 The Positive Fate of Biochar Addition to Soil in the Degradation of PHBV-Silver Nanoparticle Composites.

3 gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct

4 cholesterol-lowering action of bna-based antisense oligonucleotides targeting pcsk9 in atherogenic diet-induced hypercholesterolemic mice

5 gene knockdowns in adult animals: ppmos and vivo-morpholinos

6 Delivery of antisense peptide nucleic acid by gold nanoparticles for the inhibition of virus replication.

7 Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.

8 Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells.

9 Consequences of antisense down-regulation of a lignification-specific peroxidase on leaf and vascular tissue in tobacco lines demonstrating enhanced enzymic saccharification.

10 Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement.

11 Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts.

12 Application of hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry for the retention and sensitivity studies of antisense oligonucleotides.

13 Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

14 Targeting RNA decay with 2′,5′ oligoadenylate-antisense in respiratory syncytial virus-infected cells

15 Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

16 Recruiting the 2-5A system for antisense therapeutics

17 Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides

18 os dna sintéticos anti-sentido antisense synthtetic dna

19 antisense oligonucleotide mediated splice correction of a deep intronic mutation in opa1

20 functional expression study of igf2 antisense transcript in mouse

21 strategies for in vivo screening and mitigation of hepatotoxicity associated with antisense drugs

22 lrrk2 antisense oligonucleotides ameliorate α-synuclein inclusion formation in a parkinson’s disease mouse model

23 htlv deregulation of the nf-κb pathway: an update on tax and antisense proteins role

24 antisense oligonucleotide-mediated suppression of muscle glycogen synthase 1 synthesis as an approach for substrate reduction therapy of pompe disease

25 expression analysis of the long non-coding rna antisense to uchl1 (as uchl1) during dopaminergic cells’ differentiation in vitro and in neurochemical models of parkinson’s disease

26 from cryptic toward canonical pre-mrna splicing in pompe disease: a pipeline for the development of antisense oligonucleotides

27 increased mtpdh activity through antisense inhibition of mitochondrial pyruvate dehydrogenase kinase enhances inflorescence initiation, and inflorescence growth and harvest index at elevated co2 in arabidopsis thaliana

28 the novel anaerobiosis-responsive overlapping gene ano is overlapping antisense to the annotated gene ecs2385 of escherichia coli o157:h7 sakai

29 Analysis of Antisense Expression by Whole Genome Tiling Microarrays and siRNAs Suggests Mis-Annotation of Arabidopsis Orphan Protein-Coding Genes

30 The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

31 The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy